Clinical Trials Logo

Clinical Trial Summary

Hair analysis is a well-established and important tool in both forensic and clinical context. When it comes to the interpretation of positive hair analysis results, reliable and comprehensive reference data is essential. Such data on opioids, especially novel synthetic ones (such as fentanyl and its analogues (fentalogs)) is currently highly limited. This applies especially to hair with pediatric origin, due to differences in the metabolism and hair anatomy in children compared to adults. Investigators hypothesize that opioids, both traditional and novel synthetic ones exhibit detectable concentrations and distinct metabolite ratios within the hair matrices of pediatric patients. Thus, this observational, prospective research study provides 150 hair and sweat samples from children who received opioids as part of surgery or pain management. The samples will be consecutively extracted and analyzed using a sensitive targeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) method, enabling the quantitative determination of the opioid and metabolite concentrations. The study thereby contributes valuable reference data for both forensic and clinical applications, addressing challenges in interpreting hair analysis results in especially pediatric populations. Further, a deeper understanding of the mechanisms (e.g. via sweat) and pharmacokinetic processes involved in the opioid incorporation to hair will be achieved. The study has received ethical approval from the Swiss Ethics Board (approval number: 2022-01693 / amendment approval date: 09.01.2024).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05740657
Study type Observational [Patient Registry]
Source University of Zurich
Contact Tina M. Binz, Dr.
Phone +41 44 635 7614
Email TinaMaria.Binz@irm.uzh.ch
Status Recruiting
Phase
Start date December 6, 2022
Completion date December 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06469177 - Patient Centered Post-Op Pain Management Software Tool Interventional Study Verses Standard of Care N/A
Terminated NCT02747875 - Methadone vs. Fentanyl Administration on Postoperative Pain Control in Pediatric Patients Undergoing Cardiac Surgery N/A
Completed NCT02244099 - Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic N/A
Completed NCT02282306 - Phone Interview to Prevent Recurring Opioid Overdoses N/A
Recruiting NCT03923374 - Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
Completed NCT04069403 - An Opioid Prescribing Nudge N/A
Completed NCT04155229 - EMR Defaults to Nudge Opioid Prescribing N/A
Completed NCT02299024 - Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter N/A
Recruiting NCT04564729 - Shared Decision Aid for Post-Total Knee Arthroplasty Opioid Prescribing N/A
Active, not recruiting NCT05283980 - Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement Phase 2/Phase 3
Completed NCT04854551 - Opioid Modulation and Neural Reward Activation in Healthy Adults Phase 1/Phase 2
Recruiting NCT06050551 - Pigtail or Chest Tube Placement After Uniportal Video-assisted Thoracoscopic Surgery N/A
Completed NCT04928339 - Pecto-Intercostal Fascial Plane Block Study Phase 4
Completed NCT03773484 - Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase N/A
Completed NCT02653144 - the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block Phase 4
Enrolling by invitation NCT05875857 - Patient Utilization of Opioid Destruction Bags in the Post op Period N/A
Recruiting NCT04275258 - Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder N/A
Completed NCT04252443 - Nurses' Knowledge and Attitude About Opioids N/A
Recruiting NCT05242081 - Study on Opioid-free Anesthesia Protocol With S-ketamine and Propofol N/A
Completed NCT02431793 - EHR‐Based Medication Complete Communication Strategy to Promote Safe Opioid Use N/A